Low Bleeding Profile With Asundexian Seen in Pooled Analysis
Low bleeding liability with the XIa inhibitor may mean higher doses are possible, boosting efficacy, one investigator suggested.
Source: tctmd.com
Stay updated with breaking news from Johnw Eikelboom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Low bleeding liability with the XIa inhibitor may mean higher doses are possible, boosting efficacy, one investigator suggested.
Compared with reduced-dose prophylaxis, full-dose anticoagulation cut thrombotic events but also boosted bleeding in patients with COVID-19 who needed ICU admission.